114 related articles for article (PubMed ID: 21273658)
1. Effect of metyrapone on the fluoxetine-induced change in extracellular dopamine, serotonin and their metabolites in the rat frontal cortex.
Rogóż Z; Gołembiowska K
Pharmacol Rep; 2010; 62(6):1015-22. PubMed ID: 21273658
[TBL] [Abstract][Full Text] [Related]
2. Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex.
Kamińska K; Gołembiowska K; Rogóż Z
Pharmacol Rep; 2013; 65(5):1144-51. PubMed ID: 24399710
[TBL] [Abstract][Full Text] [Related]
3. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Dawson LA; Li P
J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
[TBL] [Abstract][Full Text] [Related]
4. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
Li XM; Perry KW; Wong DT
Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
[TBL] [Abstract][Full Text] [Related]
5. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
Yoshino T; Nisijima K; Katoh S; Yui K; Nakamura M
Neurochem Int; 2002 Apr; 40(4):355-60. PubMed ID: 11792466
[TBL] [Abstract][Full Text] [Related]
6. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats.
Gobert A; Rivet JM; Cistarelli JM; Millan MJ
J Neurochem; 1997 Mar; 68(3):1326-9. PubMed ID: 9048781
[TBL] [Abstract][Full Text] [Related]
7. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study.
Koch S; Perry KW; Nelson DL; Conway RG; Threlkeld PG; Bymaster FP
Neuropsychopharmacology; 2002 Dec; 27(6):949-59. PubMed ID: 12464452
[TBL] [Abstract][Full Text] [Related]
8. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
[TBL] [Abstract][Full Text] [Related]
9. 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex.
Lacroix LP; Dawson LA; Hagan JJ; Heidbreder CA
Synapse; 2004 Feb; 51(2):158-64. PubMed ID: 14618683
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
Dawson LA; Nguyen HQ; Smith DL; Schechter LE
J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
[TBL] [Abstract][Full Text] [Related]
11. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine.
Jordan S; Kramer GL; Zukas PK; Moeller M; Petty F
Synapse; 1994 Dec; 18(4):294-7. PubMed ID: 7886621
[TBL] [Abstract][Full Text] [Related]
12. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.
Ago Y; Nakamura S; Baba A; Matsuda T
Neuropsychopharmacology; 2005 Jan; 30(1):43-51. PubMed ID: 15383832
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.
Zhang W; Perry KW; Wong DT; Potts BD; Bao J; Tollefson GD; Bymaster FP
Neuropsychopharmacology; 2000 Sep; 23(3):250-62. PubMed ID: 10942849
[TBL] [Abstract][Full Text] [Related]
14. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.
Johansson D; Falk A; Marcus MM; Svensson TH
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):143-8. PubMed ID: 22691715
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.
Liu YP; Wilkinson LS; Robbins TW
Psychopharmacology (Berl); 2004 Apr; 173(1-2):175-85. PubMed ID: 14726995
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
[TBL] [Abstract][Full Text] [Related]
18. The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus.
Dawson LA; Nguyen HQ; Li P
Neuropsychopharmacology; 2001 Nov; 25(5):662-8. PubMed ID: 11682249
[TBL] [Abstract][Full Text] [Related]
19. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
20. Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex.
Matsumoto M; Togashi H; Mori K; Ueno K; Miyamoto A; Yoshioka M
Eur J Pharmacol; 1999 Oct; 383(1):39-48. PubMed ID: 10556679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
